Page last updated: 2024-10-31

moclobemide and Heart Failure

moclobemide has been researched along with Heart Failure in 2 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huuskonen, C1
Hämäläinen, M1
Paavonen, T1
Moilanen, E1
Mennander, A1
Hale, AS1

Reviews

1 review available for moclobemide and Heart Failure

ArticleYear
New antidepressants: use in high-risk patients.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Age Factors; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Epilep

1993

Other Studies

1 other study available for moclobemide and Heart Failure

ArticleYear
Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload.
    Anatolian journal of cardiology, 2019, Volume: 21, Issue:1

    Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Heart Failure; Moclobemide; Monoamine Ox

2019